Tuberculin Purified Protein Derivate for Intradermal Injection

[02 February 2015]

Products Affected - Description

There are no products affected.

Reason for the Shortage

  • Sanofi Pasteur states the shortage was due to production delays.
  • Par Sterile Products (formerly JHP) states the shortage was due to increased demand for the product.

Available Products

Aplisol, Par Sterile Products (formerly JHP Pharmaceuticals)
5 tuberculin units/0.1 mL, 1 mL (10 tests), multiple dose vial (NDC 42023-0104-01)
5 tuberculin units/0.1 mL, 5 mL (50 tests), multiple dose vial (NDC 42023-0104-05)
Tubersol, Sanofi Pasteur
5 tuberculin units/0.1 mL, 1 mL (10 tests), multiple dose vial (NDC 49281-0752-21)
5 tuberculin units/0.1 mL, 5 mL (50 tests), multiple dose vial (NDC 49281-0752-22)

Estimated Resupply Dates

Aplisol and Tubersol vials are available.


February 2, 2015; September 10, 2014; August 13, 2014; July 14, 2014; May 12, 2014; March 24, 2014; March 6, 2014; January 23, 2014; October 15, 2013; September 16, 2013; July 29, 2013; June 3, 2013; May 15, 2013; April 12, 2013; April 1, 2013; March 7, 2013; January 24, 2013; December 10 2012; November 14, 2012, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing